Cannabis Bioscience International Holdings, Inc.
corporate_fare Company Profile
Cannabis Bioscience International Holdings, Inc. (OTC:CBIH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for CBIH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-22, rated 7/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for CBIH spans 10-Q.
Recent high-impact activity:
- CBIH Signs First VitaCookies Licensing Deal, Initiating Commercial Rollout
- Cannabis Bioscience International Holdings Reports Near-Zero Cash, Worsening Financials, and Ineffective Controls Amidst Going Concern Warning
- Going Concern Warning, Ineffective Controls, and Deteriorating Financials Highlight Severe Risks
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 10,000 shares in CBIH as of the September 15, 2026 settlement, a 100.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On September 28, 2026, 66.7% of CBIH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.